Published in Proc Natl Acad Sci U S A on May 01, 2006
A newly identified bocavirus species in human stool. J Infect Dis (2009) 3.25
Multiple diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces. J Virol (2009) 2.70
Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis (2010) 2.19
High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. J Infect Dis (2009) 1.78
Parenteral transmission of the novel human parvovirus PARV4. Emerg Infect Dis (2007) 1.76
Comparative analysis reveals frequent recombination in the parvoviruses. J Gen Virol (2007) 1.64
Parvoviruses PARV4/5 in hepatitis C virus-infected patient. Emerg Infect Dis (2007) 1.57
Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild. J Virol (2010) 1.42
Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections. J Virol (2008) 1.39
Parvovirus among patients with cytopenia of unknown origin in Brazil: a case-control study. J Clin Microbiol (2011) 1.39
Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa. Emerg Infect Dis (2010) 1.36
Transmission networks and population turnover of echovirus 30. J Virol (2008) 1.25
Human bocavirus in children with acute lymphoblastic leukemia. Eur J Pediatr (2007) 1.17
Advances in human B19 erythrovirus biology. J Virol (2010) 1.10
Discovery and genomic characterization of a novel ovine partetravirus and a new genotype of bovine partetravirus. PLoS One (2011) 1.10
Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors. Transfusion (2011) 1.09
What is for dinner? Viral metagenomics of US store bought beef, pork, and chicken. Virology (2014) 1.08
Frequent cross-species transmission of parvoviruses among diverse carnivore hosts. J Virol (2012) 1.07
High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J Infect Dis (2011) 1.05
Biological and immunological relations among human parvovirus B19 genotypes 1 to 3. J Virol (2007) 1.00
Genomic features of the human bocaviruses. Future Virol (2012) 0.97
Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence. PLoS One (2010) 0.94
From orphan virus to pathogen: the path to the clinical lab. Curr Opin Virol (2011) 0.90
Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies. Clin Rheumatol (2007) 0.89
High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol (2008) 0.89
Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients. BMC Infect Dis (2013) 0.88
Phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J Clin Microbiol (2009) 0.87
NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy. PLoS One (2008) 0.86
Human Parvoviruses. Clin Microbiol Rev (2017) 0.84
Detection of human parvovirus B19 in papillary thyroid carcinoma. Br J Cancer (2008) 0.83
Genetic variants of human parvovirus B19 in South Africa: cocirculation of three genotypes and identification of a novel subtype of genotype 1. J Clin Microbiol (2009) 0.83
Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure. Circ Heart Fail (2010) 0.83
Chlamydia-Like Organisms (CLOs) in Finnish Ixodes ricinus Ticks and Human Skin. Microorganisms (2016) 0.82
Predictors of outcome in patients with parvovirus B19 positive endomyocardial biopsy. Clin Res Cardiol (2015) 0.82
Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression. PLoS One (2012) 0.81
Molecular characterization of human parvovirus B19 genotypes 2 and 3. Virology (2009) 0.81
Human immunodeficiency virus/human parvovirus B19 co-infection in blood donors and AIDS patients in Sichuan, China. Blood Transfus (2012) 0.80
Molecular phenotypes of human parvovirus B19 in patients with myocarditis. World J Cardiol (2014) 0.80
Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study. J Clin Microbiol (2014) 0.80
Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter? Transfusion (2012) 0.78
Bones hold the key to DNA virus history and epidemiology. Sci Rep (2015) 0.77
Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis. Arthritis Res Ther (2007) 0.77
Genetic characterization of parvoviruses circulating in turkey and chicken flocks in Poland. Arch Virol (2012) 0.77
Human parvovirus 4 'PARV4' remains elusive despite a decade of study. F1000Res (2017) 0.77
Parvovirus B19 - Revised. Transfus Med Hemother (2010) 0.77
Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay. J Clin Microbiol (2013) 0.76
Extinct type of human parvovirus B19 persists in tonsillar B cells. Nat Commun (2017) 0.75
Granzyme B mediated function of Parvovirus B19-specific CD4(+) T cells. Clin Transl Immunology (2015) 0.75
Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes. Virol J (2016) 0.75
The MOGE(S) classification for cardiomyopathies: current status and future outlook. Heart Fail Rev (2017) 0.75
Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A (2005) 14.71
Retrospective birth dating of cells in humans. Cell (2005) 5.60
New DNA viruses identified in patients with acute viral infection syndrome. J Virol (2005) 5.26
Characteristics and taxonomy of Parvoviridae. Intervirology (1985) 3.70
High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation (2005) 3.06
Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet (1997) 2.86
High rate of viral evolution associated with the emergence of carnivore parvovirus. Proc Natl Acad Sci U S A (2004) 2.83
Replication of the B19 parvovirus in human bone marrow cell cultures. Science (1986) 2.75
Genetic diversity within human erythroviruses: identification of three genotypes. J Virol (2002) 2.18
Rapid diagnosis of hantavirus disease with an IgG-avidity assay. Lancet (1991) 1.79
Identification and characterization of a second novel human erythrovirus variant, A6. Virology (2002) 1.53
Microbial DNA in the synovium--a role in aetiology or a mere bystander? Lancet (1997) 1.51
Parvovirus B19 DNA is frequently present in recombinant coagulation factor VIII products. Thromb Haemost (1996) 1.46
Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A (1998) 1.45
Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood (2003) 1.45
Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol (2004) 1.43
A new parvovirus genotype persistent in human skin. Virology (2002) 1.40
Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood (2005) 1.39
Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma. J Virol Methods (2004) 1.38
Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. J Clin Microbiol (2006) 1.35
Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol (1999) 1.33
Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini. Virology (1990) 1.31
Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis (1995) 1.31
The structure of human parvovirus B19. Proc Natl Acad Sci U S A (2004) 1.30
Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol (1997) 1.27
Parvovirus B19-induced apoptosis of hepatocytes. J Virol (2004) 1.26
Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris) (2002) 1.24
Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J Infect Dis (1998) 1.20
Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J Med Virol (2005) 1.18
Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis (1995) 1.16
Sequence variability among different parvovirus B19 isolates. J Gen Virol (1996) 1.16
High mutant frequency in populations of a DNA virus allows evasion from antibody therapy in an immunodeficient host. J Virol (2003) 1.14
Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol (2004) 1.13
Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis (2003) 1.13
Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics. J Clin Virol (2005) 1.12
Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. J Infect Dis (1993) 1.08
Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis (2005) 1.08
Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol (2001) 1.06
Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J Gen Virol (2000) 1.06
Identification of a novel RNA splicing pattern as a basis of restricted cell tropism of erythrovirus B19. Virology (2000) 1.05
Human parvovirus B19 infection of monocytic cell line U937 and antibody-dependent enhancement. Virology (2005) 1.04
Epidemiology of Sindbis virus infections in Finland 1981-96: possible factors explaining a peculiar disease pattern. Epidemiol Infect (2002) 0.98
Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue. J Clin Microbiol (2005) 0.97
Human parvovirus (B19) and erythema infectiosum. J Pediatr (1985) 0.95
Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization. Mod Pathol (2004) 0.93
Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR). J Med Virol (2002) 0.92
Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study. J Infect Dis (2004) 0.91
Prokaryotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay. J Clin Microbiol (1992) 0.89
Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells. J Virol (2005) 0.88
Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol (2006) 0.85
Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: characterization by PCR and B-cell molecular immunology. Scand J Infect Dis (1997) 0.84
Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2. Thromb Haemost (2004) 0.84
No association between human parvovirus B19 and testicular germ cell cancer. J Gen Virol (2002) 0.78
Hantavirus infections in Europe. Lancet Infect Dis (2003) 5.27
A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev (2010) 4.64
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Tick-borne encephalitis. Lancet (2008) 2.99
Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis (2009) 2.86
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood (2007) 2.82
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Serodiagnosis of human bocavirus infection. Clin Infect Dis (2008) 2.72
The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci U S A (2003) 2.62
Activation of fibroblasts in cancer stroma. Exp Cell Res (2010) 2.19
Atypical Ormond's disease associated with bile duct stricture mimicking cholangiocarcinoma. Scand J Gastroenterol (2009) 2.17
Intrahepatic IL-8 producing Foxp3⁺CD4⁺ regulatory T cells and fibrogenesis in chronic hepatitis C. J Hepatol (2013) 2.03
Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland. Emerg Infect Dis (2009) 1.87
Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment. J Gen Virol (2006) 1.86
Serologically verified human bocavirus pneumonia in children. Pediatr Pulmonol (2010) 1.85
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81
Limb ischemic preconditioning reduces heart and lung injury after an open heart operation in infants. Pediatr Cardiol (2009) 1.81
Human bocavirus-the first 5 years. Rev Med Virol (2011) 1.81
Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis (2002) 1.81
Hantavirus infections in Europe and their impact on public health. Rev Med Virol (2012) 1.77
Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland. Emerg Infect Dis (2012) 1.67
Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Am J Surg Pathol (2004) 1.66
A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines. Clin Infect Dis (2012) 1.63
Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappaB activation in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum (2008) 1.61
Infections preceding early arthritis in southern Sweden: a prospective population-based study. J Rheumatol (2003) 1.59
Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer (2003) 1.57
Cowpox with severe generalized eruption, Finland. Emerg Infect Dis (2003) 1.55
Cyclic hantavirus epidemics in humans--predicted by rodent host dynamics. Epidemics (2009) 1.53
Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol (2002) 1.48
Persistence of novel human parvovirus PARV4 in liver tissue of adults. J Med Virol (2008) 1.47
Pitfalls in the diagnosis of intestinal tuberculosis: a case report. Scand J Gastroenterol (2005) 1.46
Fatal parvovirus B19 myocarditis in an 8-year-old boy. J Forensic Sci (2003) 1.45
Establishment of a reverse genetics system for studying human bocavirus in human airway epithelia. PLoS Pathog (2012) 1.43
Low TNF-induced NF-kappaB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford) (2010) 1.43
Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild. J Virol (2010) 1.42
A new parvovirus genotype persistent in human skin. Virology (2002) 1.40
Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections. J Virol (2008) 1.39
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. Eur J Cancer (2006) 1.38
Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol (2004) 1.37
Seroepidemiology of human bocaviruses 1-4. J Infect Dis (2011) 1.37
Early diagnosis of dengue in travelers: comparison of a novel real-time RT-PCR, NS1 antigen detection and serology. J Clin Virol (2009) 1.36
Isolation, identification, and characterization of novel arenaviruses, the etiological agents of boid inclusion body disease. J Virol (2013) 1.35
Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining. J Pathol (2005) 1.35
Long-lived memory T lymphocyte responses after hantavirus infection. J Exp Med (2002) 1.34
Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol (2010) 1.34
Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses. J Virol (2010) 1.33
Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter. J Med Virol (2007) 1.32
Dating of human bocavirus infection with protein-denaturing IgG-avidity assays-Secondary immune activations are ubiquitous in immunocompetent adults. J Clin Virol (2010) 1.32
Hypophyseal hemorrhage and panhypopituitarism during Puumala Virus Infection: Magnetic Resonance Imaging and detection of viral antigen in the hypophysis. Clin Infect Dis (2002) 1.31
Mechanisms of glycerophospholipid homeostasis in mammalian cells. Prog Lipid Res (2011) 1.30
Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections. Eur J Pediatr (2006) 1.29
Siberian subtype tickborne encephalitis virus, Finland. Emerg Infect Dis (2006) 1.28
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis (2013) 1.28
Seroepidemiology of the newly found trichodysplasia spinulosa-associated polyomavirus. J Infect Dis (2011) 1.28
Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells. Virology (2005) 1.27
Severe human bocavirus infection, Germany. Emerg Infect Dis (2011) 1.27
How to diagnose hantavirus infections and detect them in rodents and insectivores. Rev Med Virol (2008) 1.26
Characterization of a novel flavivirus from mosquitoes in northern europe that is related to mosquito-borne flaviviruses of the tropics. J Virol (2009) 1.26
Human bocavirus in patients with encephalitis, Sri Lanka, 2009-2010. Emerg Infect Dis (2013) 1.25
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Hum Pathol (2008) 1.25
c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant. Mod Pathol (2002) 1.24
Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris) (2002) 1.24
Serodiagnosis of primary infections with human parvovirus 4, Finland. Emerg Infect Dis (2011) 1.22
Mapping of the regions involved in homotypic interactions of Tula hantavirus N protein. J Virol (2003) 1.22
Real-time quantitative PCR detection of four human bocaviruses. J Clin Microbiol (2010) 1.20
Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion (2002) 1.19
Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients. Gynecol Oncol (2003) 1.19
Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J Infect Dis (2002) 1.18